Several factors impact the appearance and treatment of scar after an injury. Topical scar treatment, laser treatment, and invasive surgical treatment are some of the options for scar tenement. Topical products and various procedures are used for the treatment of scars such as surgery, steroid injections, cryotherapy, and pressure treatment or gel pads with silicone.
North America scar treatment market is estimated to account for US$ 3,731.9 Mn in terms of value in 2019 and is expected to reach US$ 5,043.8 Mn by the end of 2027.
North America Scar Treatment Market: Drivers
Increasing demand for cosmetic laser and light devices is expected to boost growth of North America scar treatment market. These home use devices use various technologies such as intense pulsed light (IPL) and light-emitting diodes (LED).
North America Scar Treatment Market: Opportunities
Increasing demand for longer lasting dermal filler option is expected to offer lucrative growth opportunities for players in the market. For instance, according to a survey by The Harris Poll in 2018, around 8 million of the 9 million patients who have had dermal fillers, are experiencing filler fatigue.
North America Scar Treatment Market: Restraints
Lack of skilled professionals in the treatment of scars is expected to hamper growth of the market. Imparting improper training to the professional conducting the scar treatment may result in adverse or serious side effects.
Topical sub segment in product type segment in North America scar treatment market was valued at US$ 2,222.8 Mn in 2018 and is expected to reach US$ 3,061.4 Mn by 2027 at a CAGR of 3.6% during the forecast period.
Topical medications offer several advantages over other treatment options such as availability of wide variety of options, low costs, easy application of treatments, and others. These factors are expected to support growth of the segment over the forecast period.
The topical treatment sub segment in treatment type segment held dominant position in North America scar treatment market in 2018, accounting for 61.7% share in terms of value, followed by surface treatment, and laser treatment, respectively.
The hospitals sub segment in end user segment held dominant position in North America scar treatment market in 2018, accounting for 38.0% share in terms of value, followed by clinics and Pharmacies and Drug Stores, respectively.
Patients have to frequently visit their nearest hospitals for treatment and consultation which is expected to support growth of the market over the forecast period.
The use of VR in treatment of scars is increasing in the recent past. For instance, HTC Corporation’s HTC VIVE, a VR system is under clinical trial for assessing the effect of virtual reality technology on decreasing the acute pain of scar treatment with fractional laser under local anesthesia. The study is expected to be completed in December 2020.
Key players in the market are also focused on product development to expand their product portfolio. For instance, in October 2018, Sonoma Pharmaceuticals, Inc. launched Ceramax Skin Barrier Lotion.
North America Scar Treatment Market: Competitive Landscape
Major players operating in North America scar treatment market include, Smith & Nephew Inc., Merz Inc., Enaltus LLC, Oculus Innovative Sciences, Inc., CCA Industries, Cynosure, Inc., Avita Medical, LUTRONIC, Janssen Biotech, Inc., Luminus Inc., Syneron Medical Ltd., and NutraMarks, Inc.
North America Scar Treatment Market: Key Developments
Key players in the market are focused on adopting inorganic growth strategies to expand their product portfolio. For instance, in November 2019, AVITA Medical collaborated with the Gates Center for Regenerative Medicine at the University Of Colorado School Of Medicine to establish proof-of-concept and explore further development of a spray-on treatment of genetically modified cells for patients with epidermolysis bullosa (EB) and other genetic skin disorders.
Key players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in January 2019, Suneva Medical, Inc. partnered with Healeon Medical, Inc and Puregraft, LLC. in order to expand its product portfolio in regenerative aesthetics.
“*” marked represents similar segmentation in other categories in the respective section.